Cargando…
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia
Aceruloplasminemia is a monogenic disease caused by mutations in the ceruloplasmin gene that result in loss of protein ferroxidase activity. Ceruloplasmin plays a role in iron homeostasis, and its activity impairment leads to iron accumulation in liver, pancreas, and brain. Iron deposition promotes...
Autores principales: | Zanardi, Alan, Conti, Antonio, Cremonesi, Marco, D'Adamo, Patrizia, Gilberti, Enrica, Apostoli, Pietro, Cannistraci, Carlo Vittorio, Piperno, Alberto, David, Samuel, Alessio, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760856/ https://www.ncbi.nlm.nih.gov/pubmed/29183916 http://dx.doi.org/10.15252/emmm.201708361 |
Ejemplares similares
-
Aceruloplasminemia: Waiting for an Efficient Therapy
por: Piperno, Alberto, et al.
Publicado: (2018) -
Ceruloplasmin-Deficient Mice Show Dysregulation of Lipid Metabolism in Liver and Adipose Tissue Reduced by a Protein Replacement
por: Raia, Sara, et al.
Publicado: (2023) -
Pancytopenia and Myelodysplastic Changes in Aceruloplasminemia: A Case with a Novel Pathogenic Variant in the Ceruloplasmin Gene
por: Yamamura, Ayako, et al.
Publicado: (2018) -
Ceruloplasmin Deamidation in Neurodegeneration: From Loss to Gain of Function
por: Zanardi, Alan, et al.
Publicado: (2021) -
Aceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report)
por: Hayashida, Maiko, et al.
Publicado: (2016)